https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/acromegaly/ 2024-05-29T06:03:05+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/advanced-cancer/ 2024-05-29T06:00:50+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/advanced-epithelioid-sarcoma/ 2024-05-29T06:02:03+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/advanced-malignant-solid-tumor/ 2024-05-29T06:01:58+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/advanced-or-metastatic-gastric-carcinoma/ 2024-05-29T05:58:27+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/advanced-or-metastatic-hepatocellular-cancer/ 2024-05-29T05:58:27+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/advanced-or-metastatic-ovarian-cancer/ 2024-05-29T05:58:27+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/advanced-prostate-cancer/ 2024-05-29T06:00:26+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/advanced-soft-tissue-sarcoma/ 2024-05-29T06:02:03+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/advanced-solid-tumors/ 2024-05-29T06:02:07+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/alagille-syndrome/ 2024-05-29T05:58:56+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/arm-spasticity/ 2024-05-29T05:59:25+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/atypical-teratoid-rhabdoid-tumors/ 2024-05-29T06:02:01+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/biliary-atresia/ 2024-05-29T05:58:58+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/bone-cancer/ 2024-05-29T06:00:50+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/breast-cancer/ 2024-05-29T06:03:46+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/carcinoid-syndrome/ 2024-05-29T05:58:19+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/castration-resistant/ 2024-05-29T05:58:25+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/central-precocious-puberty/ 2024-05-29T06:00:28+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/cerebral-palsy/ 2024-05-29T06:04:27+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/cerebrovascular-accident/ 2024-05-29T05:59:33+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/cervical-dystonia/ 2024-05-29T06:03:50+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/children/ 2024-05-29T06:04:13+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/chronic-migraine/ 2024-05-29T05:59:42+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/chronic-plantar-fasciitis/ 2024-05-29T05:59:21+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/chronic-renal-insufficiency/ 2024-05-29T05:58:13+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/chronic-scar-pain/ 2024-05-29T06:01:21+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/colorectal-cancer/ 2024-05-29T06:00:50+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/detrusor-muscle-hyperactivity/ 2024-05-29T06:04:03+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/diarrhea/ 2024-05-29T06:02:57+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/diffuse-large-b-cell-lymphoma-refractory/ 2024-05-29T06:03:34+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/diffuse-large-b-cell-lymphoma/ 2024-05-29T06:03:34+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/diffuse-large-b-cell-lymphoma-dlbcl/ 2024-05-29T06:01:28+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/dwarfism/ 2024-05-29T05:58:13+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/endocrine-tumors/ 2024-05-29T05:57:26+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/endometrial-cancer/ 2024-05-29T06:03:43+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/endometriosis/ 2024-05-29T06:00:25+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/episodic-migraine/ 2024-05-29T05:59:44+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/epitheliod-sarcoma/ 2024-05-29T06:02:07+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/epithelioid-sarcoma/ 2024-05-29T06:02:01+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/epithelioid-sarcoma-es/ 2024-05-29T06:01:28+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/er-pr-positive-breast-cancer/ 2024-05-29T06:02:59+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/exostoses/ 2024-05-29T06:03:32+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/ezh2-gain-of-function-mutation/ 2024-05-29T06:02:01+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/fibrodysplasia-ossificans-progressiva/ 2024-05-29T06:03:31+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/fibrodysplasia-ossificans-progressiva-fop/ 2024-05-29T05:59:53+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/follicular-lymphoma/ 2024-05-29T06:02:07+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/follicular-lymphoma-fl/ 2024-05-29T06:01:28+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/gastric-cancer/ 2024-05-29T06:00:50+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/gastro-enteropancreatic-neuroendocrine-tumor/ 2024-05-29T06:00:34+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/gastroenteropancreatic-neuroendocrine-tumor/ 2024-05-29T06:00:29+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/gastroenteropancreatic-neuroendocrine-tumors/ 2024-05-29T06:03:06+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/glabellar-frown-lines/ 2024-05-29T06:03:54+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/glabellar-lines/ 2024-05-29T06:04:07+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/growth-disorders/ 2024-05-29T06:03:35+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/hallux-abducto-valgus/ 2024-05-29T06:01:20+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/head-and-neck-squamous-cell-carcinoma/ 2024-05-29T05:59:39+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/healthy-participants/ 2024-05-29T06:01:22+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/healthy-volunteers/ 2024-05-29T06:00:02+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/hemifacial-spasm/ 2024-05-29T05:58:42+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/hepatic-impairment/ 2024-05-29T06:01:58+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/huntingtons-disease/ 2024-05-29T05:58:22+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/insulin-like-growth-factor-1-deficiency/ 2024-05-29T06:03:36+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/intestinal-obstruction/ 2024-05-29T05:59:05+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/lateral-canthal-lines/ 2024-05-29T06:04:26+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/leg-spasticity/ 2024-05-29T06:04:08+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/locally-advanced-or-metastatic-renal-cell-carcinoma/ 2024-05-29T06:02:11+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/locally-advanced-prostate-cancer/ 2024-05-29T06:00:26+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/low-back-pain/ 2024-05-29T05:58:43+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/malignancies-hematologic-malignancy/ 2024-05-29T06:01:28+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/malignancy/ 2024-05-29T06:01:28+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/malignant-carcinoid-syndrome/ 2024-05-29T05:57:19+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/malignant-rhabdoid-tumor/ 2024-05-29T06:02:01+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/malignant-solid-tumour/ 2024-05-29T05:57:36+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/melanoma/ 2024-05-29T05:59:39+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/mesothelioma/ 2024-05-29T06:02:07+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/metastatic-adenocarcinoma-of-the-pancreas/ 2024-05-29T06:01:25+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/metastatic-breast-cancer-with-active-brain-metastasis/ 2024-05-29T06:02:59+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/metastatic-castrate-resistant-prostate-cancer/ 2024-05-29T05:58:23+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/metastatic-pancreatic-adenocarcinoma/ 2024-05-29T06:01:24+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/metastatic-prostate-cancer/ 2024-05-29T06:01:30+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/metastatic-renal-cell-cancer/ 2024-05-29T05:58:27+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/metastatic-tumours/ 2024-05-29T06:00:50+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/midgut-neuroendocrine-tumours/ 2024-05-29T05:58:36+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/moderate-to-severe-glabellar-lines/ 2024-05-29T06:04:06+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/moderate-to-severe-upper-facial-lines/ 2024-05-29T06:00:53+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/moderate-upper-facial-lines/ 2024-05-29T06:01:23+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/multiple-hereditary/ 2024-05-29T06:03:32+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/multiple-myeloma/ 2024-05-29T06:03:34+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/muscle/ 2024-05-29T06:02:10+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/muscle-spasticity/ 2024-05-29T06:04:13+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/myofascial-pain-syndromes/ 2024-05-29T06:03:48+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/nervous-system-disorders/ 2024-05-29T06:03:54+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/neuroendocrine-tumors/ 2024-05-29T06:00:48+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/neuroendocrine-tumors-in-lung/ 2024-05-29T05:59:36+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/neuroendocrine-tumour-with-carcinoid-symptoms/ 2024-05-29T05:59:24+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/neuroendocrine-tumours/ 2024-05-29T05:59:23+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/non-functioning-entero-pancreatic-endocrine-tumour/ 2024-05-29T05:57:30+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/non-hodgkin-lymphoma/ 2024-05-29T06:02:07+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/non-hodgkin-lymphoma-nhl/ 2024-05-29T06:01:28+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/osteosarcomaosteosarcoma-in-children/ 2024-05-29T05:59:45+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/overactive-bladder/ 2024-05-29T06:04:14+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/pancreatic-cancer/ 2024-05-29T06:03:03+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/pancreatic-ductal-adenocarcinoma/ 2024-05-29T06:00:50+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/pancreatic-tumours/ 2024-05-29T05:58:36+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/parkinsons-disease/ 2024-05-29T06:03:50+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/pituitary-diseases/ 2024-05-29T05:58:13+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/poorly-differentiated-chordoma/ 2024-05-29T06:02:01+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/post-stroke-spasticity/ 2024-05-29T06:04:11+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/precocious-puberty/ 2024-05-29T05:57:23+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/primary-biliary-cholangitis/ 2024-05-29T06:02:12+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/primary-biliary-cholangitis-pbc/ 2024-05-29T06:00:06+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/primary-sclerosing-cholangitis/ 2024-05-29T06:00:04+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/progressive-familiar-intrahepatic-cholestasis/ 2024-05-29T05:58:47+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/prostate-cancer/ 2024-05-29T06:03:36+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/prostatic-neoplasms/ 2024-05-29T05:58:25+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/recurrent-disease/ 2024-05-29T06:00:50+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/refractory-follicular-lymphoma/ 2024-05-29T06:02:05+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/relapse-refractory-multiple-myeloma/ 2024-05-29T06:03:34+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/relapsed-follicular-lymphoma/ 2024-05-29T06:02:05+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/renal-impairment/ 2024-05-29T06:00:32+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/renal-medullary-carcinoma/ 2024-05-29T06:02:07+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/rhabdoid-tumor/ 2024-05-29T06:02:01+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/rhabdoid-tumor-of-the-kidney/ 2024-05-29T06:02:01+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/severe-upper-facial-lines/ 2024-05-29T06:01:23+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/small-cell-lung-cancer/ 2024-05-29T06:03:01+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/small-cell-lung-cancer-and-breast-cancer/ 2024-05-29T06:00:46+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/solid-tumor/ 2024-05-29T06:02:01+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/solid-tumors/ 2024-05-29T06:02:59+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/spastic-hemiparesis/ 2024-05-29T06:02:09+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/spasticity/ 2024-05-29T06:02:10+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/spasticity-post-traumatic-brain-injury/ 2024-05-29T06:04:11+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/squamous-cell-carcinoma-of-the-head-and-neck/ 2024-05-29T06:00:50+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/stroke/ 2024-05-29T06:04:23+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/synovial-sarcoma/ 2024-05-29T06:02:07+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/thyroid-associated-ophthalmopathy/ 2024-05-29T05:59:02+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/triple-negative-breast-cancer/ 2024-05-29T06:02:59+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/turner-syndrome/ 2024-05-29T05:58:13+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/upper-limb-spasticity/ 2024-05-29T06:04:23+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/upper-limb-spasticity-altered-skeletal-muscle-performance-in-children/ 2024-05-29T06:03:59+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/urinary-incontinence/ 2024-05-29T06:00:59+00:00 https://ipsencom-staging.go-vip.net/annualreport/clinical_study_indications/vulvodynia/ 2024-05-29T06:01:18+00:00